Exposure of lung microvascular endothelial cells, smooth muscle cells and fibroblasts to IL-6/IL-6Rα induced a KP-metabolite profile similar to that observed in PAH patients, suggesting that IL-6/IL-6Rα signaling likely contribute to KP activation in PAH patients. Here, IL6R is linked to pulmonary arterial hypertension.